When is it advantageous to use botulinum toxin to treat spasticity?

Botulinum toxin type A (BoNT/A) is recommended as a first-line therapy in national and international guidelines as part of an integrated treatment approach for post-stroke spasticity.

Botulinum toxin creates a ‘window of opportunity’ for improving motor and activity performance3 and should always be followed by physical therapy.

  • Please note that if you submit information to Merz all materials submitted by electronic or physical communication will be deemed non confidential. Do not submit any information or other materials that you consider to be confidential or proprietary. While we have no intention to publicly disclose any details of your proposal, we may refer to select experts within or outside the Merz network for evaluation.

  • This field is for validation purposes and should be left unchanged.